# Strata Critical Medical share price today (Strata Critical Medical, Inc., SRTA)

> Strata Critical Medical, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. SRTA · Healthcare · Medical Care Facilities · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/srta

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $4.44 (−11.7% in a year)
- P/E: 9.1× (lower than 79% of the last 1 year)
- Revenue (Jun 2026): $72.5 M (+60.7% on a year ago)
- Profit (Jun 2026): −$10.5 M
- Operating margin: −6.3% (+4.0 points on a year ago)
- ROE: 15%, FY25

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. ## What is the Strata Critical Medical share price today? Strata Critical Medical, Inc.'s share price was $4.44 at the close on 3 November 2026. That is 12.6% below its average price over the last 200 trading days. In the last 52 weeks it traded between $4 and $6, and at that close it sat 18% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 12 weeks running. Over the last 1 year the share price moved +7% while the S&P 500 moved +21%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 14 August 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Strata Critical Medical pay? Strata Critical Medical, Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Strata Critical Medical on? Strata Critical Medical is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Strata Critical Medical profitable? Strata Critical Medical, Inc. posted a net loss of $10.5 M in the Jun 2026 quarter. Full-year FY25 profit was $41.3 M. That loss is 14.5% of the quarter's revenue. The same quarter a year earlier lost $3.7 M. 9 of the last 12 reported quarters were loss-making. ## How much revenue does Strata Critical Medical make, and is it growing? Strata Critical Medical, Inc. reported $72.5 M of revenue in the Jun 2026 quarter, +60.7% on the same quarter a year earlier. That is the 4th quarter in a row with growth on the year before. Over 4 years it has grown 30.9% a year on average. The last full year, FY25, came in at $197 M. The last four reported quarters add to $256 M. FY25 revenue was $197 M, +34.3% on the year before. Recent pace: the last four quarters grew +67.1% on average, against 30.9% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +66.8%, against +5.2% a year over the last 8 quarters (accelerating). ## How much of every $100 of sales does Strata Critical Medical keep? Strata Critical Medical, Inc.'s operating margin was −6.3% in the Jun 2026 quarter, 4.0 percentage points higher than the same quarter a year ago. Across 5 years it has been between −48.0% and −6.4%. The latest quarter is above every full year in that period. Why the margin moved: operating margin changed +4.0 percentage points on the year while gross margin changed +1.0 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Strata Critical Medical's profit turning into cash? Strata Critical Medical, Inc.'s cash-flow history is too short to judge how much of its profit turns into cash. In FY25 its operations used $48.9 M of cash, against $41.3 M of profit. After $9.6 M of spending on assets, free cash was −$58.5 M: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Strata Critical Medical's cash go? Strata Critical Medical, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $42.6 M on assets over the last 3 years. Averaged over those years that is 7.2% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $42.6 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Strata Critical Medical's P/E ratio, and how does it compare with its own history? Strata Critical Medical, Inc.'s P/E is 9.1×, near the low end of its own history: it has been lower only 21% of the time. Its usual P/E (the middle reading) is 9.9×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Strata Critical Medical business getting better or worse? Strata Critical Medical, Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Strata Critical Medical earn on its capital? Strata Critical Medical, Inc. earned a ROE of 15% in FY25. That is up from a low of −24% in FY23. Its return on capital used (ROIC) is 20.9 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 21.0% net margin and 0.61× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 21.0% net margin × 0.61× asset turnover × 1.17× leverage (assets divided by equity) ≈ 15.0% on equity. The margin does most of the work; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: −2.7% − 18.2% = −20.9 percentage points. The 18.2% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Strata Critical Medical have too much debt? Strata Critical Medical, Inc. has total debt of $4.3 M against shareholder equity of $279 M as of Jun 2026, so its debt is 0.02× its equity, which is very little. Year by year, that ratio went from 0.00 in FY21 to 0.01 in FY25. So the returns on this page come from the business, not from borrowed money. ## What is the Strata Critical Medical shareholding pattern? 7.8% of Strata Critical Medical, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 5.6 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Strata Critical Medical from balance-sheet trouble? For Strata Critical Medical, Inc., the Z-score is 5.38. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 5.38 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does Strata Critical Medical rank in its industry? There is no score against its industry: Strata Critical Medical, Inc. is not among the largest members shown in this industry comparison for Medical Care Facilities. The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown. ## Which companies is Strata Critical Medical compared with? No sector comparison is shown here, not among the largest members shown in this industry comparison. ## Which companies are close to Strata Critical Medical in size? Strata Critical Medical is the 36th largest of 38 Medical Care Facilities companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: GMR Solutions Inc., The Oncology Institute, Inc., Charming Medical and Cross Country Healthcare, Inc. Just below it: Auna S.A. and Community Health Systems, Inc. ### Medical Care Facilities companies close in size

1. [GMR Solutions Inc.](https://www.sectoralpha.in/us/stocks/gmrs) $885 million
2. [The Oncology Institute, Inc.](https://www.sectoralpha.in/us/stocks/toi) $646 million
3. [Charming Medical Limited](https://www.sectoralpha.in/us/stocks/mcta) $504 million
4. [Cross Country Healthcare, Inc.](https://www.sectoralpha.in/us/stocks/ccrn) $428 million
5. Strata Critical Medical, Inc. $393 million
6. [Auna S.A.](https://www.sectoralpha.in/us/stocks/auna) $334 million
7. [Community Health Systems, Inc.](https://www.sectoralpha.in/us/stocks/cyh) $278 million

[All 38 Medical Care Facilities companies, largest first](https://www.sectoralpha.in/us/sectors/medical-care-facilities#all-companies)

### Companies close in size in other industries

1. [Codere Online Luxembourg, S.A.](https://www.sectoralpha.in/us/stocks/cdro) $393 million · Gambling
2. [Redwood Trust, Inc.](https://www.sectoralpha.in/us/stocks/rwt) $393 million · REIT - Mortgage
3. Strata Critical Medical, Inc. $393 million
4. [LendingTree, Inc.](https://www.sectoralpha.in/us/stocks/tree) $392 million · Financial Conglomerates
5. [Caledonia Mining Corporation Plc](https://www.sectoralpha.in/us/stocks/cmcl) $392 million · Gold

## What else do people ask about Strata Critical Medical? ### What were Strata Critical Medical's latest quarterly results? Strata Critical Medical, Inc. reported revenue of $72.5 M and a net loss of $10.5 M for the Jun 2026 quarter. Earnings per share were −$0.12. The operating margin was −6.3%, 4.0 percentage points higher than a year earlier (as of 3 November 2026). ### What is Strata Critical Medical's market cap? Strata Critical Medical, Inc.'s market capitalisation is $393 M at a stock price of $4.44. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Strata Critical Medical performing? Strata Critical Medical, Inc.'s latest readings are below. Over the past 13 weeks it has done worse than the S&P 500, for 12 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Strata Critical Medical's stock price go up? This page does not forecast Strata Critical Medical, Inc.'s stock price. What it shows instead: the stock price is $4.44. Its P/E of 9.1× is higher than 21% of its own last 1 years. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Where is Strata Critical Medical in its business cycle? Strata Critical Medical, Inc.'s FY25 operating margin was −6.4%, against a 5-year range of −48.0% to −6.4%: the middle of its own range, neither a peak nor a low. The latest quarter was −6.3%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Strata Critical Medical story? Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Strata Critical Medical a stock worth studying right now? What the numbers show: Strata Critical Medical, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.